Emerald Advisers’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-802,610
| Closed | -$11.8M | – | 244 |
|
|
2023
Q4 | $11.8M | Sell |
802,610
-35,962
| -4% | -$529K | 0.51% | 83 |
|
|
2023
Q3 | $15.4M | Buy |
838,572
+6,764
| +0.8% | +$124K | 0.74% | 57 |
|
|
2023
Q2 | $17.9M | Sell |
831,808
-141,027
| -14% | -$3.04M | 0.79% | 59 |
|
|
2023
Q1 | $28.5M | Buy |
972,835
+135,926
| +16% | +$3.99M | 1.37% | 14 |
|
|
2022
Q4 | $30.9M | Buy |
836,909
+235,683
| +39% | +$8.71M | 1.49% | 11 |
|
|
2022
Q3 | $16.9M | Buy |
+601,226
| New | +$16.9M | 0.87% | 48 |
|